Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women

American Journal of Drug and Alcohol Abuse

Volumn 34, Issue 2, 2008, Pages 161-170

  Kapadia, Farzana ^a,j   Vlahov, David ^a   Wu, Yingfeng ^a   Cohen, Mardge H ^b   Greenblatt, Ruth M ^c   Howard, Andrea A ^d   Cook, Judith A ^e   Goparaju, Lakshmi ^f   Golub, Elizabeth ^g   Richardson, Jean ^h   Wilson, Tracey E ⁱ  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e Mental Health Services Research NRTC   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^j GUTTMACHER INSTITUTE   (United States)

more..

Author keywords

Adherence; Antiretroviral therapy; Drug abuse treatment modality; Human immunodeficiency virus

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG; METHADONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA ANALYSIS; DRUG DEPENDENCE; DRUG USE; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; SUBSTANCE ABUSE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 39749190588     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990701877052     Document Type: Article

References (23)

1. Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg, RS. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 2003; 169:656-661.
2. Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002; 17:377-381.
3. Wilson TE, Barron Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, Young M. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis 2002; 34:529-534.
4. Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr 2001; 27:251-259.
5. Stein MD, Rich JD, Maksad J, Chen MH, Hu P, Sobota M, Clarke J. Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. Am J Drug Alcohol Abuse 2000; 26:195-205.
6. Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS. 2000; 14:151-155.
7. Avants SK, Margolin A, Warburton LA, Hawkins KA, Shi J. Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. Am J Addict 2001; 10:69-78.
8. Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug Alcohol Depend 2006; 84:188-194.
9. Cumberbatch Z, Copersino M, Stitzer M, Jones H. Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment. Am J Drug Alcohol Abuse 2004; 30:237-249.
10. Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug Alcohol Depend 2006.
11. Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse 2003; 29:19-53.
12. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-125.
13. DHHS and Henry J. Kaiser Family Foundation. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, February 2001 revision.
14. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30.
15. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 385;1:US.
16. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977; 106:203-214.
17. Hardin JW. Generalized Estimating Equations. Boca Raton: Chapman & Hall/CRC Press, 2002.
18. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
19. Brown LS, Jr., Kritz SA, Goldsmith RJ, Bini EJ, Rotrosen J, Baker S, Robinson J, McAuliffe P. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 2006; 30:315-321.
20. Conway B, Prasad J, Reynolds R, Farley J, Jones M, Jutha S, Smith N, Mead A, DeVlaming S. Directly observed therapy for the management of HIV-infected patients in a methadone program. Clin Infect Dis 2004; 38 Suppl 5:S402-S408.
21. Lucas GM, Weidle PJ, Hader S, Moore RD. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clin Infect Dis 2004; 38 Suppl 5:S409-S413.
22. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004; 19:1111-1117.
23. Sharpe TT, Lee LM, Nakashima AK, Elam-Evans LD, Fleming PL. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. J Community Health 2004; 29:117-127.